piperidine has been researched along with Pain in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Journigan, VB; Khroyan, TV; Polgar, WE; Zaveri, NT | 1 |
Albrecht, C; Bartolozzi, A; Berry, AK; Ceci, A; Cirillo, PF; Gemkow, MJ; Hickey, ER; Nagaraja, NV; Riether, D; Romig, H; Sauer, A; Thomson, DS; Wu, L; Zindell, R | 1 |
Diaz, JL; Holenz, J; Oberdorf, C; Schepmann, D; Vela, JM; Wünsch, B | 1 |
Ahn, K; Beidler, D; Bhattacharya, K; Cravatt, BF; Johnson, DS; Kamtekar, S; Lazerwith, S; Liimatta, M; Long, JZ; McKinney, MK; Mileni, M; Sadagopan, N; Smith, SE; Stevens, RC; Stiff, C; Swaney, S; Van Becelaere, K; Weerapana, E; Zhang, Y | 1 |
Bennett, C; Bridal, T; Burnett, DA; Correll, CC; Czarniecki, M; Dong, Z; Greenlee, WJ; Jia, YP; Kieselgof, J; Kim, HM; Knutson, C; McKittrick, BA; Mullins, D; Nechuta, TL; Priestley, T; Rindgen, D; Smith, EM; Sorota, S; Tan, Z; Tulshian, D; Zhang, X; Zhou, X | 1 |
5 other study(ies) available for piperidine and Pain
Article | Year |
---|---|
Designing bifunctional NOP receptor-mu opioid receptor ligands from NOP-receptor selective scaffolds. Part II.
Topics: Analgesics; Animals; Ligands; Mice; Models, Animal; Nociceptin Receptor; Pain; Piperidines; Protein Binding; Receptors, Opioid; Receptors, Opioid, mu; Structure-Activity Relationship | 2014 |
Selective CB2 receptor agonists. Part 3: the optimization of a piperidine-based series that demonstrated efficacy in an in vivo neuropathic pain model.
Topics: Animals; Diabetic Neuropathies; Half-Life; Humans; Ligands; Male; Microsomes, Liver; Pain; Pipecolic Acids; Piperidines; Protein Binding; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Solubility; Structure-Activity Relationship; Thiazines | 2015 |
Thiophene bioisosteres of spirocyclic sigma receptor ligands. 1. N-substituted spiro[piperidine-4,4'-thieno[3,2-c]pyrans].
Topics: Alkylation; Animals; Cyclization; Ligands; Mice; Models, Molecular; Molecular Structure; Oxidation-Reduction; Pain; Piperidines; Protein Binding; Pyrans; Rats; Receptors, sigma; Spiro Compounds; Structure-Activity Relationship; Thiophenes | 2008 |
Discovery and characterization of a highly selective FAAH inhibitor that reduces inflammatory pain.
Topics: Amidohydrolases; Animals; Arachidonic Acids; Brain; Crystallography, X-Ray; Endocannabinoids; Enzyme Inhibitors; Humans; Male; Pain; Piperazine; Piperazines; Piperidines; Polyunsaturated Alkamides; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid; Structure-Activity Relationship; Urea | 2009 |
T-type calcium channel blockers: spiro-piperidine azetidines and azetidinones-optimization, design and synthesis.
Topics: Animals; Azetidines; Calcium Channel Blockers; Calcium Channels, T-Type; Drug Design; Humans; Pain; Piperidines; Protein Binding; Rats; Spiro Compounds; Structure-Activity Relationship | 2010 |